iCardio.ai
iCardio.ai30
About
What does iCardio.ai do?
iCardio.ai develops AI-powered solutions to automate echocardiographic analysis, including EchoMeasure™ for automated echo measurements and CardioVision™ for auto-detecting aortic stenosis. They partner with ultrasound companies to deliver their technology to clinicians and enterprises, aiming to integrate AI into cardiac imaging pipelines. The company also offers data for projects and expert interpretations assisted by AI.
What is iCardio.ai's revenue?
StartupHub estimates iCardio.ai's annual revenue at $3.6M (range $3.1M to $8.9M, 68% confidence), based on comparable companies in the sector.
Where is iCardio.ai headquartered?
iCardio.ai is headquartered in Tel Aviv, Israel.
When was iCardio.ai founded?
iCardio.ai was founded in 2019.
What industry does iCardio.ai operate in?
iCardio.ai operates in Healthcare, Ultrasound, Medical Imaging, HealthTech, MedTech, AI-Driven Protein Design.
How many employees does iCardio.ai have?
iCardio.ai has approximately 19 people on record.
Ultimed develops an AI-powered platform to streamline medical imaging analysis and reporting for radiologists.
Antaros Medical provides innovative imaging solutions and insights for clinical drug development in metabolic, fibrotic, and inflammatory diseases.
Developing innovative AI-powered surgical navigation and planning solutions for enhanced surgical outcomes.
An entrant is a company tagged Medical Imaging whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.